Venrock Healthcare Capital Partners III, L.P., 10% Owner at Bellerophon Therapeutics, Inc. (BLPH), bought 675,000 shares at $1.22 ($786K) on 2018-09-10, disclosed to the SEC on 2018-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 200,000 | $244K | 31.0% |
| 2 | $1.14 | 200,000 | $228K | 29.0% |
| 3 | $1.14 | 200,000 | $228K | 29.0% |
| 4 | $1.15 | 75,000 | $86K | 11.0% |
| Total | $1.16 avg | 675,000 | $786K | 100% |
| Filing → |
| KALV | BUY | 2024-02-01 | $2.5M | — | Filing → |
| KALV | BUY | 2024-01-29 | $1.4M | — | Filing → |
| KALV | BUY | 2024-01-10 | $2.8M | — | Filing → |